Needle Biopsy
Needle Biopsy is a medical procedure with 16 clinical trials. Currently 2 active trials ongoing. Historical success rate of 76.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
71.4%
10 of 14 finished
28.6%
4 ended early
2
trials recruiting
16
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
14 g vs. 16 g in Breast Biopsy
Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
Clinical Trials (16)
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
14 g vs. 16 g in Breast Biopsy
Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations
Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery
Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer
Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules
Laser Spectroscopy of Breast Tissue Through a Needle Device
Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer
Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment
All 16 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 16